Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AP01 inhaled pirfenidone access and safety study in progressive fibrosing interstitial lung disease
NL-OMON52355Phase 2Recruiting
- Sponsor
- Avalyn Pharmaceuticals
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of pirfenidone, sponsored by Avalyn Pharmaceuticals. Started Jul 2021; status: recruiting.
02
Drugs
pirfenidone
Beyond the preview
Go deeper on NL-OMON52355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52355.